Breaking news: Scotland refuses to treat majority of people with spinal muscular atrophy
Scotland annouces very restricted access to Spinraza, depriving the majority of SMA patients of an effective treatment
Scotland annouces very restricted access to Spinraza, depriving the majority of SMA patients of an effective treatment
Australia will allocate 240 million Australian dollars to fund the break-through Spinraza treatment for those with spinal muscular atrophy.
Scotland annouces very restricted access to Spinraza, depriving the majority of SMA patients of an effective treatment
Australia will allocate 240 million Australian dollars to fund the break-through Spinraza treatment for those with spinal muscular atrophy.
Update on the regulatory appraisal process of Spinraza in England and Wales
Update on the regulatory appraisal process of Spinraza in England and Wales